New Era of Immune-Based Therapy in Intrahepatic Cholangiocarcinoma

SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma is the second most common primary liver malignancy after hepatocellular carcinoma and accounts for 20% of biliary tract cancers. The incidence of biliary tract cancer has been increasing in recent years, and many patients with biliary tract cancer are...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Etsushi, Matsubara, Tsutomu, Kawada, Norifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417782/
https://www.ncbi.nlm.nih.gov/pubmed/37568808
http://dx.doi.org/10.3390/cancers15153993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417782/
https://www.ncbi.nlm.nih.gov/pubmed/37568808
http://dx.doi.org/10.3390/cancers15153993

Ejemplares similares